publicações selecionadas
-
artigo académico
- Optimizing Acoustic Stimulation for Tissue Engineering: A Non-Invasive Approach to Combat Triple Negative Breast Cancer Cells. Advanced Healthcare Materials. 2025
- Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review. International Journal of Molecular Sciences. 2023
- Selective Cytotoxicity of Portuguese Propolis Ethyl Acetate Fraction towards Renal Cancer Cells. Biomolecules. 2022
-
artigo de conferência
-
documento
- Epigenetic modulation of kdm4c as a therapeutic strategy for triple-negative breast cancer 2025
- Design de novos inibidores da KDM4C para o tratamento do cancro da mama triplo negativo 2025
- Acoustic stimulation based on piezoelectric materials enhanced antiproliferative activity of triple-negative breast cancer cells 2025
- KDM4C epigenetic therapy for triple-negative breast cancer 2024
- Piezoelectric material-based acoustic stimulation enhanced anti-proliferative activity of triple negative breast cancer cells 2024
- Design of new epigenetic inhibitors for the treatment of triple negative breast cancer 2024
- Therapeutic epigenetic KDM4C remodeling for the treatment of triple negative breast cancer 2024
- Acoustic stimulation based on piezoelectric materials for reducing the proliferation of triple negative breast cancer cells 2024
- Virtual screening of potential KDM4C inhibitors for the treatment of triple negative breast cancer 2023
- Chromene-based molecules: privileged scaffold for oncology drug development 2023
- Development of virtual screening protocols for the design of novel KDM4C inhibitors for the treatment of triple negative breast cancer 2023
- Optimization of specialized virtual screening protocols for the design of new KDM4C inhibitor molecules for the treatment of triple negative breast cancer 2023
- Otimização de protocolos especializados de virtual screening para o design de novas moléculas inibidoras da KDM4C para o tratamento do cancro da mama triplo negativo 2023
- Treatment of triple-negative breast cancer through externally triggered target-less drug carriers 2023
- In vitro validation of a new magnetic solid lipid nanoformulation against Triple-Negative Breast Cancer 2021
- Validação de uma nova nanoformulação direcionada para o diagnóstico e tratamento do cancro da mama triplo-negativo 2021
- Engineered exosome-mediated delivery of RNAi therapeutics towards triple negative breast cancer therapy 2021
- In vitro validation of new theranostic nanoformulation against Triple-negative breast cancer 2021
- In vitro validation of a new magnetic formulation against Trile-negative breast cancer 2021
- Anti-cancer activity of Portuguese propolis fractions and isolated compounds 2021
- Characterization of the biological activity of functionalized chromeno[2,3-b]pyridines for breast cancer treatment 2020
- New substituted 3,5-dihydro-4H-chromeno [2,3-d] pyrimidin-4-one: a promising strategy for breast cancer treatment 2020
- Unravelling the anticancer potential of novel compounds for breast cancer therapy 2020
- Chromene derivatives: a new strategy to overcome renal cancer resistance 2019
- Exploitation of novel chromene derivatives for breast cancer treatment 2019
- New molecules based on chromene moiety as candidates for renal cell carcinoma therapy 2019
- Synthesis and biological activity of new anticancer agents for breast cancer treatment 2019
- New chromene derivatives: Unraveling the molecular mechanisms for breast cancer therapy 2019
- Chromene-based compounds as candidates for renal cell cancer treatment 2019
- Synthesis of functionalized chromeno[2,3-b]pyridines: promising agents for breast cancer treatment 2019
- Biological activity of novel targeted inhibitors for renal cell cancer therapy 2019
- In vitro and in vivo evaluation of new chromene derivatives as potent anticancer agents 2019
- Chromene-based molecules as targeted inhibitors for renal cell cancer therapy 2019
- New chromene-based molecules as microtubule destabilizers and pro-apoptotic agents in cancer 2018
- Chemical and biological characterization of chalcones and 4H-chromenes: exploitation as anticancer agents 2018
- Unraveling the anticancer molecular mechanisms of new chromene-based drugs 2018
- Discovery of chromene-based molecules as apoptosis-inducers by G2/M cell-arrest 2018
- Chromene-based drug candidates for cancer treatment 2018